Israel's Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)'s Institute for Psychedelic Research ...
Authorized to sell psilocybin through Health Canada's Special Access Program. "Receiving this licence is a significant achievement for APEX alongside our tremendous progress actively dosing patients ...
The APEX-002-A01-03 randomized, double-blind, placebo-controlled phase 2b study plans to recruit patients across Canada to evaluate the efficacy, safety and tolerability of APEX-52, a microdose, ...
An American laboratory specializing in home phlebotomy has disclosed a cyber-attack that occurred five months ago after data stolen in the attack turned up online. Apex Laboratory opened in 1997 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results